Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0095489 PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or...
2017/0095488 COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN...
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid, can be used to treat or alleviate pain or...
2017/0095487 Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain...
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions such as...
2017/0095486 CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT PAIN
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid and neridronic acid in an acid or a salt form,...
2017/0095485 METHODS AND COMPOUNDS TO INHIBIT ENVELOPED VIRUS RELEASE
A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an...
2017/0095484 METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING...
A method of treating resistant non-Hodgkin lymphoma, medulloblastoma, and/or ALK+ non-small cell lung cancer in a mammal by administering a solid dispersion...
2017/0095483 DGAT1 INHIBITION FOR TREATMENT OF DEMYELINATING INFLAMMATORY DISEASE
Methods are provided for treating autoimmune disease in a subject by inhibiting the activity of DGAT1.
2017/0095482 PHARMACEUTICAL COMBINATION COMPRISING A CLASS III RECEPTOR TYROSINE KINASE INHIBITOR AND THE ALKYLATING...
The present invention is directed to a combination comprising a class III receptor tyrosine kinase inhibitor and a compound of formula I or a pharmaceutically...
2017/0095481 Compounds That Enhance ATOH1 Expression
This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression...
2017/0095480 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE AS MODULATORS OF GPR139
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: ##STR00001## which are...
2017/0095479 Methods for Treating Cancer with a WEE1 Inhibitor
The present invention relates generally to the use of gene mutations, whose presence or absence are useful for predicting a patient's response to treatment...
2017/0095478 COMBINATION THERAPY TO ENHANCE THE ANTICANCER EFFICACY OF PLATINUM DRUGS
The present invention relates to compositions and methods for reducing cell proliferation and/or promoting cell death. It is based, at least in part, on the...
2017/0095477 PHARMACEUTICAL COMPOSITION COMPRISING A TRIAZOLE ANTIFUNGAL AGENT AND METHOD FOR PREPARATION THEREOF
The present invention relates to a stable pharmaceutical formulation of solid dosage forms for oral administration comprising a therapeutically effective...
2017/0095476 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful...
2017/0095475 HETEROARYL COMPOUNDS AND USES THEREOF
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
2017/0095474 COMPOUNDS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
The invention described herein pertains to the treatment of multiple sclerosis. In particular, the invention described herein pertains to the treatment of...
2017/0095473 COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGY AGENTS
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase...
2017/0095472 NOVEL N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4- ,3-a]PYRAZINES AS SELECTIVE NK-3...
A method for treating and/or preventing hot flashes, by administering, to a patient in need thereof, of a pharmaceutically effective amount of a compound of...
2017/0095471 Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
Therapeutic methods of treating chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) are described. In certain embodiments, the invention...
2017/0095470 Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of...
The present disclosure provides an extended release pharmaceutical composition comprising hydrocodone and acetaminophen that provides a rapid onset of...
2017/0095469 QUATERNARY OPIOID CARBOXAMIDES
Compounds of formulas: ##STR00001## are disclosed. The compounds are useful for ameliorating the side effects of therapeutic opiates.
2017/0095468 TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF
This invention provides transdermal non-patch pergolide formulations useful for the treatment of disease in an equine. The invention also provides methods for...
2017/0095467 ENCAPSULATION OF ISOQUINOLINE ALKALOIDS
Processes of extracting isoquinoline alkaloids from natural sources and encapsulating the alkaloids in an alginate and inulin matrix are provided. The...
2017/0095466 PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING...
The present invention relates to a method for treating skin diseases and skin conditions in a patient in need thereof which comprises of administering a...
2017/0095465 METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Methods for the treatment of CNS disorders using combinations of muscarinic activators and inhibitors, and medicaments comprising muscarinic activators and...
2017/0095464 METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF CERTAIN...
Methods of treating, preventing or managing leukemias are disclosed. The methods encompass the administration of an immunomodulatory compound of the invention...
2017/0095463 COMBINATION OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR AND A MTOR INHIBITOR
The present invention relates to a pharmaceutical combination comprising a phosphatidylinositol-3-kinase (PI3K) inhibitor compound which is a 2-carboxamide...
2017/0095462 METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM
Disclosed are methods of modulating a stress activated protein kinase (SAPK) system with an active compound, wherein the active compound exhibits low potency...
2017/0095461 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
This invention relates to novel substituted benzamide according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical...
2017/0095460 COMBINATION THERAPIES FOR TREATING CANCER
Provided are methods for treating cancer in a patient by administering at least antibiotic selected from the group consisting of clofazamine, rifabutin and...
2017/0095459 NITROXIDES FOR USE IN TREATING OR PREVENTING DIABETES AND OBESITY
Pharmaceutical compositions are provided that are useful in treating diabetes. The compositions comprise a pharmaceutically acceptable carrier, and an...
2017/0095458 HETEROARYL SULFONAMIDES AND CCR2/CCR9
Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating...
2017/0095457 COMPOSITIONS AND METHODS OF DELIVERY OF DEUBIQUITINASE INHIBITORS
Described herein are compositions comprising deubiquitinase inhibitors in combination with albumin, methods of making such compositions, and methods of using...
2017/0095456 Therapeutic and Method of Use
The present invention is a method of treating ETD and in particular a method of treating endometriosis and adenomyosis by administering a compound comprised of...
2017/0095455 UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF NAPROXEN SODIUM AND NIZATIDINE
Described herein are immediate release unit oral solid dose compositions composed of naproxen sodium and nizatidine. The compositions described herein are...
2017/0095454 ORAL TRANSMUCOSAL COMPOSITIONS INCLUDING AROMATASE INHIBITORS FOR TREATING FEMALE INFERTILITY
Formulations for oral transmucosal compositions including aromatase inhibitors (AIs) in combination with transmucosal absorption enhancers are disclosed. Oral...
2017/0095453 Low Dose Pharmaceutical Composition
This invention provides a low dose pharmaceutical composition comprising deferasirox or a pharmaceutically acceptable derivative thereof and one or more...
2017/0095452 Oral Dosage Forms of Bendamustine
In the present invention there is provided an oral pharmaceutical composition, comprising bendamustine or a pharmaceutically acceptable, ester, salt or solvate...
2017/0095451 COMPOSITION INCLUDING INDOPROFEN AND USE THEREOF
A method of increasing PGC-1.alpha. expression in a mammalian cell, the method comprising administering an effective amount of indoprofen, a pharmaceutically...
2017/0095450 Lipoxygenase Inhibitors
The disclosure provides bisindole suitable for inhibiting lipoxygenases or A.beta.-formation, and treating associated diseases, such as Alzheimer's disease....
2017/0095449 PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND THEIR USE AS THERAPEUTIC...
This invention is directed to pharmaceutical compositions for topical administration to a mammal, wherein the pharmaceutical compositions comprise a...
2017/0095448 Novel Formulation of Indomethacin
The present invention relates to methods for producing particles of indomethacin using dry milling processes as well as compositions comprising indomethacin,...
2017/0095447 METHODS OF ADIPOLYSIS AND COMPOSITIONS USEFUL THEREIN
Provided herein are pharmacologically active compositions suitable for topical application or injection directly for fat treatment without the need for...
2017/0095446 SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF
This invention provides novel indole, indazole, benzimidazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (SARD)...
2017/0095445 COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG
Methods are for treatment of an inflammatory disease of the lung caused by inhalation of a toxic agent or an irritant, such as chlorine inhalational lung...
2017/0095444 STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof,...
2017/0095443 CAFFEOYLQUINIC ACID-RICH EXTRACT AND PREPARATION AS WELL AS USE THEREOF
A caffeoylquinic acid-rich extract obtained from Erigeron multiradiatus and a method for producing the same. A caffeoylquinic acid-rich extract includes at...
2017/0095442 Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
Provided are methods of treating diarrhea, particularly malabsorption diarrhea, in neonatal, young and adult non-human animals, in which the diarrhea results...
2017/0095441 FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and...
2017/0095440 METHOD OF TREATING CANINE PANCREATITIS
A method for treating pancreatitis that involves identifying a patient with pancreatitis and administering to the patient a daily dose of Camostat Mesilate of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.